Esperion Therapeutics Inc.

(NASDAQ:ESPR) Trade

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing oral therapies for the treatment of patients with elevated low-density lipoprotein cholesterol. The firm has Business of researching, developing and commercializing therapies for the treatment of patients with the elevated LDL-C operating segment.

Contact Information

Website: www.esperion.com
Email: aschwartz@esperion.com
Main Phone: +1 734 887-3903
Address: 3891 Ranchero Drive
Address 2: Suite 150
State: MI
City / Town: Ann Arbor
Country: US
Postal Code: 48108

Issuer Information

Exchange: NSD
CEO: Timothy M. Mayleben
Employees: 479
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A